Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Hsu

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
BMC Gastroenterology|January 25, 2014
Risk factors for second primary neoplasia of esophagus in newly diagnosed head and neck cancer patients: a case-control studyChen-Shuan Chung, Li-Jen Liao, Wu-Chia Lo, et al.
Scientific Reports|July 31, 2019
Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer modelsChun-Ting Kuo, Chen-Lin Chen, Chih-Chi Li, et al.
Journal of Gastrointestinal Oncology|November 18, 2024
Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinomaHung-Wei Wang, Hsueh-Chou Lai, Wen-Pang Su, et al.
Transplantation|May 1, 2026
Systemic Treatment Strategies for Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A 20-y Retrospective Analysis With Clinical InsightsShih-Chao Hsu, Horng-Ren Yang, Sheng-Hsien Chen, et al.
Annals of Transplantation|March 24, 2026
Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving StrategyShih-Chao Hsu, Sheng-Hsien Chen, Te-Hong Chen, et al.
Scientific Reports|August 20, 2020
Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer modelsChun-Ting Kuo, Chen-Lin Chen, Chih-Chi Li, et al.
Nanomaterials (Basel, Switzerland)|April 30, 2021
Graphene Nanosheet-Wrapped Mesoporous La<sub>0.8</sub>Ce<sub>0.2</sub>Fe<sub>0.5</sub>Mn<sub>0.5</sub>O<sub>3</sub> Perovskite Oxide Composite for Improved Oxygen Reaction Electro-Kinetics and Li-O<sub>2</sub> Battery ApplicationChelladurai Karuppiah, Chao-Nan Wei, Natarajan Karikalan, et al.
Canadian Journal of Gastroenterology & Hepatology|July 15, 2022
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis CSheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, et al.
BMC Gastroenterology|April 29, 2019
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agentsWei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, et al.
Scientific Reports|April 13, 2018
Publisher Correction: New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitisHung-Wei Wang, Cheng-Yuan Peng, Hsueh-Chou Lai, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
BMC Gastroenterology|January 25, 2014
Risk factors for second primary neoplasia of esophagus in newly diagnosed head and neck cancer patients: a case-control studyChen-Shuan Chung, Li-Jen Liao, Wu-Chia Lo, et al.
Scientific Reports|July 31, 2019
Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer modelsChun-Ting Kuo, Chen-Lin Chen, Chih-Chi Li, et al.
Journal of Gastrointestinal Oncology|November 18, 2024
Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinomaHung-Wei Wang, Hsueh-Chou Lai, Wen-Pang Su, et al.
Transplantation|May 1, 2026
Systemic Treatment Strategies for Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A 20-y Retrospective Analysis With Clinical InsightsShih-Chao Hsu, Horng-Ren Yang, Sheng-Hsien Chen, et al.
Annals of Transplantation|March 24, 2026
Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving StrategyShih-Chao Hsu, Sheng-Hsien Chen, Te-Hong Chen, et al.
Scientific Reports|August 20, 2020
Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer modelsChun-Ting Kuo, Chen-Lin Chen, Chih-Chi Li, et al.
Nanomaterials (Basel, Switzerland)|April 30, 2021
Graphene Nanosheet-Wrapped Mesoporous La<sub>0.8</sub>Ce<sub>0.2</sub>Fe<sub>0.5</sub>Mn<sub>0.5</sub>O<sub>3</sub> Perovskite Oxide Composite for Improved Oxygen Reaction Electro-Kinetics and Li-O<sub>2</sub> Battery ApplicationChelladurai Karuppiah, Chao-Nan Wei, Natarajan Karikalan, et al.
Canadian Journal of Gastroenterology & Hepatology|July 15, 2022
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis CSheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, et al.
BMC Gastroenterology|April 29, 2019
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agentsWei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, et al.
Scientific Reports|April 13, 2018
Publisher Correction: New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitisHung-Wei Wang, Cheng-Yuan Peng, Hsueh-Chou Lai, et al.
Pageof 12